Stuart Needleman wins promotion at Aptuit
Moves from heading scientific operations to president and chief operating officer
Tim Tyson will continue as chairman, concentrating his efforts on a variety of external growth and strategic partnership opportunities.
Needleman joined Aptuit in 2006 as vice president, sales and marketing, and was later promoted to president of API development and manufacturing. In 2011, he took charge of all the company’s scientific efforts as president of Aptuit Scientific Operations. He began his career in the industry at Cambrex, and previously held senior level, global positions at Oxford Asymmetry, ChiRex, Rhodia Pharma Solutions and Arch Pharmalabs.
You may also like
Research & Development
Aptuit and Chiesi initiate discovery project to identify compounds to treat idiopathic pulmonary fibrosis
Both parties will contribute scientifically, with Aptuit providing integrated early discovery capabilities, including medicinal chemistry and pharmacology, as well as drug metabolism and pharmacokinetics, to identify promising compounds for further preclinical development
